+
Site Tour

EuroPCR 2022: Mitral replacement - expanding patient option

Francesco Maisano, Nicolus Dumonteil, Lenard Conradi, Paulo Denti, Paul Sorajja and Marianna Adamo discuss the potential for expanding patient options for mitral valve replacement as well as the treatment options for annular calcification.

 

Related Videos

EuroPCR 2022: Tendyne™

EuroPCR 2022: Leading clinical evidence

AV VALVES 2023: MR – Mixed MR

TAVI with Navitor Vision - Livecase

EACTS 2021: Transcatheter mitral valve implantation

AV VALVES 2023: MR – Acute Rupture

Navitor™: Voice of the Experts Francesco Nicolas Dumonteil

EuroPCR 2021: Advancing solutions for tricuspid regurgitation patients

Javier's testimonial

AV VALVES 2023: Trending Topics – Complexity

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

TriClip™ G4: Product overview

EuroEcho 2021: Tricuspid regurgitation: The Patient

EuroEcho 2021: MR Treatment (Patient)

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT


LIVE
RELATED EVENTS

Now you've got Navitor.
Future ready.

AV VALVES 2023: HoloLens Technology

TAVI Summit - Live case from Berlin

TAVI Case Club – Challenge of difficult access

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline